Ora Biomedical, Inc.

Longevity biotech pharma company. Discovering and developing healthy aging gerotherapeutics using robotics-AI.

[Ora Biomedical, Inc. @OraBiomedical]

Exciting news! We are bringing the #millionmoleculechallenge to you!

Become a citizen scientist with us and sponsor a compound to test for extended lifespan using the WormBot-AI!

Visit https://t.co/bieWHAnmyL to play a part in revolutionizing healthy longevity!

[Ora Biomedical, Inc. @OraBiomedical]

Our CEO Ben Blue had the privilege of speaking at H-SPAN Arizona during Arizona Tech Week — an incredible gathering of scientists, founders, investors, and innovators advancing longevity science and aging biology.

Ben joined an impressive lineup of researchers and entrepreneurs for a Quick Pitch, sharing the work we're doing at Ora Biomedical to extend healthspan and lifespan through AI-driven drug discovery.

Thank you to the The Alliance for Longevity Initiatives and H-SPAN team for putting together such a thoughtful and inspiring event, and to everyone who stopped to connect during the networking session. The energy around longevity science in Arizona is something special — we're grateful to be part of it!

https://t.co/euhGnf8QXX

#Longevity #Healthspan #AgingBiology #Geroscience #AZTechWeek

[Ora Biomedical, Inc. @OraBiomedical]

Most longevity biotech companies are testing what we already know.

We're not.

Real biology. Live models. 1,000x the scale. No guesswork.

This is what reimagining drug discovery looks like.

#DrugDiscovery #Geroscience #Longevity

[Krister Kauppi - Rapamycin Longevity Lab @KristerKauppi]

Together we've now reached 42% funding of the second subproject in the largest lifespan analysis of 601 mTOR modulators. The goal with this project is to uncover the next breakthrough beyond the mTOR inhibitor Rapamycin, which is currently the most promising longevity compound due to its effects across multiple species. But there are likely even more potent longevity compounds waiting to be discovered and that’s exactly what this project is all about!

A huge thank you to Ciarán Murray for his generous support for the longevity research project! All this support is making a real difference in advancing longevity research and generating unique data that no one else has delivered to the field before. This large dataset will be publicly available for everyone, providing an important foundation for labs, researchers and AI to progress beyond basic studies toward more advanced and impactful longevity research.

The current gold sponsors are

✅ Ciarán Murray: a longevity enthusiast and tech founder of @OlasProtocol. Connect with him on X via @C1aranMurray

✅ Anonymouse: A anonymous contribution by Anonymouse

Other sponsors of the project

✅ Rapamycin Longevity Lab: The mission is to become the leading experts in combinational longevity therapies in which we use a mTOR inhibitor as a base.

✅ People in the longevity field: Big thanks for all the support! Let me know if you want to be highlighted in the next fundraising status update.

If you're passionate about longevity or want to help make a difference, we’d love for you to get involved in this historical project! Whether through sponsoring, sharing this post or even just giving it a thumbs up. Every action helps to move the needle forward. Let’s make this happen together!

PS. In July I published the top list of compounds from phase 1 of the project. Next week I will publish the bottom list of the compounds and in September the goal is to get all the data on the first 301 mTOR modulators published to Rapamycin Longevity Lab's and Ora's open databases. Step by step forward!

[Krister Kauppi - Rapamycin Longevity Lab @KristerKauppi]

We’re thrilled to announce that we’ve reached 28% funding for our second subproject, where we’ll screen the remaining 300 mTOR inhibitors! The goal is to uncover the next breakthrough beyond the mTOR inhibitor Rapamycin, which is currently the most promising longevity compound due to its effects across multiple species. But there are likely even more potent longevity compounds waiting to be discovered and that’s exactly what this project is all about!

A massive thank you to everyone who has contributed so far and especially to Anonymouse for the latest generous $10K contribution to the second subproject! All this support is making a real difference in advancing longevity research and generating unique data that no one else has delivered to the field before. This large dataset will be publicly available for everyone, providing an important foundation for labs, researchers and AI to progress beyond basic studies toward more advanced and impactful longevity research.

If you're passionate about longevity or want to help make a difference, we’d love for you to get involved in this historical project! Whether through sponsoring, sharing this post or even just giving it a thumbs up. Every action helps to move the needle forward. Let’s make this happen together!

[The Alliance for Longevity Initiatives (A4LI) @theA4LI]

𝗢𝘂𝗿 𝗗.𝗖. 𝗦𝘂𝗺𝗺𝗶𝘁 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝗕𝗿𝗶𝗲𝗳𝗶𝗻𝗴 𝗶𝘀 𝗻𝗼𝘄 𝗹𝗶𝘃𝗲 𝗼𝗻 𝗬𝗼𝘂𝗧𝘂𝗯𝗲!

We were honored to feature opening remarks from Longevity Science Caucus Co-Chairs, Representative
@RepGusBilirakis (FL-12) and Representative @RepPaulTonko (NY-20), along with @DrOz, the 17th Administrator of the Centers for Medicare & Medicaid Services.

The briefing also included insights from our distinguished panelists:
🔹 Dr. Michael Roizen — Chief Wellness Officer, Cleveland Clinic / Co-Director, Lifespan Edge
🔹 Dr. Eric Verdin — CEO & President, Buck Institute for Research on Aging
🔹 Dr. Matt Kaeberlein (@mkaeberlein) — Co-Founder & CEO, Optispan

A huge thank you to our A4LI sponsors for making this event possible. We're excited to continue working together to build bipartisan momentum for policies that extend healthy lifespans and address age-related diseases.

Watch here: https://t.co/9rnTk0gOQA.

@bioagelabs @RetroBio_ @soniaarrison @KarlPfleger @AFARorg @americanaging @ahlresearch @BuckInstitute @GordianBio @Optispan_Inc @hqlongevc @lifebiosciences @faunabio @LifespanIO @agelessrx_ @repairbio @NaNotics @ZuberLawler @matterbio @InterveneImmune @GenerationLab_ @gladdenlongevit @LifeRubedo @YuvaBio @H_L_Clinic @NFX @Rejuve_AI @HealthspanCap @edwardlando @OraBiomedical @LifeExtension @Pnoe_Analytics

[The Alliance for Longevity Initiatives (A4LI) @theA4LI]

Yesterday, we at A4LI kicked off our second annual fly-in congressional briefing — and we are proud to have been featured in the latest addition of @Politico Influence! 🧬

Thank you to @RepGusBilirakis, @RepPaulTonko & Dr. Mehmet Oz for helping us kick off a day of 50+ Hill meetings to champion longevity policy.

📰 https://t.co/tfU8rD7ZbX

[Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM @agingdoc1]

Thank you @RepGusBilirakis, @RepPaulTonko, and @DrOz for your bold bipartisan leadership at this morning’s U.S. Longevity Initiatives Congressional Briefing.

Your commitment to advancing longevity science and prevention has the power to shift public health from a reactive focus on sickspan to a proactive pursuit of healthspan for all Americans. 🇺🇸

[mohamad.base.eth @MOHAMAD_R310]

@OraBiomedical @mkaeberlein @benblueAK @BittoAlessandro @BKennedy_aging @mitchellblee33 This is such an inspiring initiative! The blend of citizen science, AI, and longevity research is exactly the kind of future-forward approach we need. Count me in—let’s help reshape the future of health, one molecule at a time.

@sharafi_eth

[The Alliance for Longevity Initiatives (A4LI) @theA4LI]

Our Congressional Briefing on Longevity Science is underway!

We're deeply grateful to our Longevity Science Caucus co-chairs, @RepGusBilirakis and @RepPaulTonko, for their inspiring opening remarks followed by insights from @DrOz.

The conversation continues with a dynamic panel discussion moderated by Founder and CEO, Dylan V. Livingston featuring Dr. Matt Kaeberlein (@mkaeberlein), Dr. Mike Roizen, and Dr. Eric Verdin (@BuckInstitute).

Let’s drive progress in the science of longer, healthier lives!

[Buck Institute @BuckInstitute]

Buck CEO Eric Verdin joins @mkaeberlein @dogagingproject and Mike Roizin from @ClevelandClinic for a day of congressional lobbying for funding for research on aging. @TheA4LI https://t.co/iX9notvnnH

[The Alliance for Longevity Initiatives (A4LI) @theA4LI]

Just launched: Defense and Space Applications of Longevity Science Panel.

Very important topics we don’t discuss often in the longevity space. Glad we are the ones to introduce it!

MC: Jeremy Elser
Chris Steele, PhD
Bob S. Walker
Mitchell Lee, PhD (@OraBiomedical)

[Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM @agingdoc1]

For those who may not be familiar, the Alliance for Longevity Initiatives (A4LI) is dedicated to advancing congressional support for increased funding and regulatory reforms related to aging biology and longevity science (geroscience). You can learn more about their work at https://t.co/6Cx4ubR4YT.

For those with prior experience engaging with congressional representatives (or their equivalents in other countries) and their staff or office liaisons, please feel free to share any insights or key takeaways you gained from those interactions.

Looking forward to connecting with many of you soon in Washington, D.C.

Feel free to connect with me as well: https://t.co/gEHdRRxB35

[Peter Fedichev @fedichev]

https://t.co/X0SoKksHsf

[Matt Kaeberlein @mkaeberlein]

This is great news leading into the @theA4LI summit next week. Huge thank you to the bipartisan group of representatives leading the way on better health for all Americans through support for longevity science.
@RepGusBilirakis (R-FL), @RepPaulTonko (D-NY), @DanCrenshawTX (R-TX), @RepRoKhanna (D-CA), @RepScottPeters (D-CA) and @RepLiccardo (D-CA)

[The Alliance for Longevity Initiatives (A4LI) @theA4LI]

The Alliance for Longevity Initiatives applauds today’s relaunch of the Congressional Caucus for Longevity Science, a bipartisan effort that signals growing momentum for policies that prioritize aging and longevity research.

Led by Representatives @RepGusBilirakis (R-FL), @RepPaulTonko (D-NY), @DanCrenshawTX (R-TX), @RepRoKhanna (D-CA), @RepScottPeters (D-CA) and @RepLiccardo (D-CA), the Caucus brings longevity science to the forefront of national policy conversations and reflects a clear commitment from Congress to extend not just lifespan, but healthspan.

You can read the full announcement from Rep. Bilirakis' office here: https://t.co/Tl0JgGVpNJ

A4LI looks forward to working alongside the Caucus to drive policies that support innovation, promote equitable access to next-generation therapies, and advance a future where everyone can live better for longer.

[Live Forever Club @liveforeverclub]

1 week until D.C. Summit 2025 @TheA4li

Speakers include:
@brookebio @eric_k_morgen @EricVerdino @bettslacroix @katerinastro @kpfortney @mkaeberlein @mitchellblee33 @soniaarrison @thelouhawthorne @AlexandraBause @DrGlorioso @KarlPfleger @PetrSramekBench

https://t.co/rC5uMgeY21

[Lifespan News @LifespanNews]

The PEARL trial tested rapamycin's effect on human healthspan and the results are in!

Learn more from lead author @SZalzalaMD of @agelessrx_, @OraBiomedical co-founder @mkaeberlein, and @LifespanIO co-founder @KeithComito:

https://t.co/oSOTZEqKom
By: Josh Conway

@LifespanRI

[The Alliance for Longevity Initiatives (A4LI) @theA4LI]

This week on A4LI’s Scientist Spotlight, we sit down with Dr. Kenneth Wilson (@_KAWilson_ ), a postdoctoral researcher in Dr. Lisa Ellerby's lab at the @BuckInstitute.

In this episode, we discuss Kenny's first contributions to the aging field, his rise to prominence, as well as his advice to young trainees looking to come into the field.

You can listen to the full episode here:https://t.co/x2pSEFdQqS.

[Ora Biomedical, Inc. @OraBiomedical]

Pioneers in aging research are telling us what we're missing.

At @OraBiomedical, we're listening.

https://t.co/CySMrw0NrQ

[Matt Kaeberlein @mkaeberlein]

I mention a few paths in the video. The @OraBiomedical Million Molecule Challenge is the one that I think has the most potential for novel intervention discovery. Large multiomic human data sets will help with personalizing and optimizing what is currently possible but unlikely to push us past ~120 or current human max lifespan IMO.